Paper · 25035397
Osteopontin shapes immunosuppression in the metastatic niche.
Sangaletti S and 11 others. Cancer Res, 2014. Cited by 130 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Osteopontin shapes immunosuppression in the metastatic niche. Papers, record 25035397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25035397
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasm Metastasis | Major topic |
| Osteopontin | Major topic |
| Animals | |
| Arginase | |
| Breast Neoplasms | |
| Cell Line, Tumor | |
| Female | |
| Humans | |
| Immune Tolerance | |
| Immunosuppression Therapy | |
| Interleukin-6 | |
| Lung Neoplasms | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Monocytes | |
| Myeloid Cells | |
| STAT3 Transcription Factor | |
| T-Lymphocytes, Regulatory |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by96
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,856,147 | Malignant epithelial diversification and inflammatory neutrophil remodeling define a transitional stage between tumor cell dissemination and overt metastatic outgrowth in breast cancer. | bioRxiv | 2026 | https://conductscience.org/library/papers/42856147 | PubMed |
| 42,509,406 | Single-cell and spatial transcriptomic landscapes reveal PIGT as a pivotal regulator of immunometabolic remodeling in colorectal cancer liver metastasis. | Funct Integr Genomics | 2026 | https://conductscience.org/library/papers/42509406 | PubMed |
| 42,469,833 | SPP1-positive macrophages drive trastuzumab resistance in HER2-positive breast cancer. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42469833 | PubMed |
| 42,399,829 | Preliminary study on the mechanism of OPN up-regulating PD-L1 to induce CD8 + T cell exhaustion in synovial sarcoma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42399829 | PubMed |
| 42,198,359 | Mechanism of Xiao-ai-fei Honey Ointment, a Traditional Uyghur Multi-Ingredient Medicinal Preparation, Against Cervical Cancer Based on Network Pharmacology and In Vitro Evaluation of Anti-Cancer Activity. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198359 | PubMed |
| 42,148,086 | Orchestrating the pre-metastatic niche: roles of stromal mediators and immune cells in metastatic progression and therapeutic targeting. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148086 | PubMed |
| 42,010,317 | Pathophysiological roles of monocytes and macrophages in cancer. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/42010317 | PubMed |
| 41,756,888 | Distinct and cooperative roles of host and tumor Osteopontin in colorectal cancer liver metastasis. | bioRxiv | 2026 | https://conductscience.org/library/papers/41756888 | PubMed |
| 41,697,520 | Research progress on the correlation between OPN and immune escape of gastric cancer. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/41697520 | PubMed |
| 41,644,583 | Proteomic atlas of human peritoneal tissue. | Sci Rep | 2026 | https://conductscience.org/library/papers/41644583 | PubMed |
1 to 10 of 96
See all 96 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SPP1 | 6,696 | PubTator's text mining | https://conductscience.org/library/genes/6696 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25035397
GET https://conductscience.org/api/papers/v1/25035397/cited_by?page=2